The National Hemophilia Foundation’s (NHF) Nursing Working Group has been revising and expanding the
We applaud all of our hard-working nurses during National Nurses Week, which begins Friday, May 6th.
Eligible candidates pursuing hemostasis and/or thrombosis research should apply now for two research-related awards.
Mark Tuesday, May 3rd as the day you will contribute to the cause to improve the lives of people with bleeding disorders in NYC.
Reserve your spot for NHF 2016 Provider Workshops Program, Highlighting Key Payer Issues and Recommended Solutions on July 23.
Reserve your spot for NHF 2016 Pre-conference Symposium on Specialty Pharmacy and Managed Care’s Role in Comprehensive Care on July 21.
Early clinical trial results in patients with hemophilia A show increased clotting factor levels in all subjects.
Patients with previous hepatitis B infection, cirrhosis or hepatocellular carcinoma need follow-up after treatment with direct-acting antivirals.
Scientists from the Indiana HTC and MicroHealth present the results of a 12-month study on the effect of HTC digital monitoring on annual bleeding rates.
NHF's Medical and Scientific Advisory Council (MASAC) issued the following three new documents, which were adopted by NHF’s Board of Directors on February 28, 2016.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car